Abdul Wasai,
Adhiraj Roy,
Mamata Barua,
Pameli Ghosh,
Anjali Saxena,
Yassir Boulaamane,
Nainee Goyal,
Anshuman Chandra,
Subrata Nath Koner,
Sandip Saha,
Biswajit Saha,
Subrata Kumar Pore,
Corrado Rizzoli,
Supratim Mandal
(2026).
Anti-cancer and dual inhibitory potential of PI3K/AKT and Ras/MAPK/ERK signalling of a novel zinc (II) trinuclear complex with tetradentate schiff base ligand and azido ion in prostate adenocarcinoma: synthesis, in silico and in vitro evaluation.
Journal Article.
Yassir Boulaamane,
Santiago Bolivar Avila,
Juan Rosales Hurtado,
Iman Touati,
Badr-Edine Sadoq,
Aamal A. Al-Mutairi,
Ali Irfan,
Sami A. Al-Hussain,
Amal Maurady,
Magdi E. A. Zaki
(2025).
Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: Insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulations.
Journal Article.
Ali Irfan,
Ameer Fawad Zahoor,
Yassir Boulaamane,
Sadia Javed,
Huma Hameed,
Amal Maurady,
Muhammed Tilahun Muhammed,
Aamal A. Al-Mutairi,
Sajjad Ahmad,
Irum Shahzadi,
Sami A. Al-Hussain,
Magdi E. A. Zaki
(2024).
Computational exploration of acefylline derivatives as MAO-B inhibitors for Parkinson’s disease: insights from molecular docking, DFT, ADMET, and molecular dynamics approaches.
Journal Article.